Showing 181-190 of 328 grants

Title Institution Researcher Program Duration Total Award Amount
Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants Stanford University Eric Appel Cures 01-January-2025 to 31-December-2026 $600,000.00
Ultrafast Insulin-Pramlintide Co-formulations Stanford University Eric Appel Improving Lives 01-September-2022 to 31-August-2025 $795,000.00
Development of Uni-molecular Glucose-responsive Insulin Stanford University Danny Hung-Chieh Chou Improving Lives 01-April-2022 to 31-March-2026 $749,998.34
Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D Stanford University Ananta Addala Improving Lives 01-February-2025 to 31-January-2029 $943,983.20
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes T1D Exchange, Inc. Nicole Rioles Improving Lives 01-May-2024 to 30-April-2027 $1,995,534.06
Research and Data Research T1D Exchange, Inc. Jaime Lucove Transportfolio 01-December-2022 to 30-November-2025 $620,435.07
Clinical Trial Recruitment T1D Exchange, Inc. Deborah Taylor Transportfolio 01-May-2023 to 30-April-2025 $264,000.00
Novel Combination Regimen Therapy to Modulate Pro- and Anti-inflammatory Lipid Signaling to Counter T1D The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-July-2022 to 30-June-2025 $600,000.00
Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-May-2023 to 30-April-2026 $749,763.00
Expanding Access to T1D Care through the PEN-Plus Strategy The Brigham and Women’s Hospital, Inc. Gene Bukhman Mission 01-August-2024 to 31-July-2027 $5,999,961.29